FindTrial
Sign In

Anticoagulant therapy for patients with portal hypertension undergoing splenectomy and devascularization

Anticoagulant therapy for patients with portal hypertension undergoing splenectomy and devascularization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12001984
Enrollment
Unknown
Registered
2012-03-04
Start date
2012-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal hypertension

Interventions

Anticoagulant group:Anticoagulant therapy
Non-anticoagulant group:No

Sponsors

Eastern Hepatobiliary Surgery Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed as portal hypertension and without malignant tumor; (2) Had a history of upper gastrointestinal bleeding or red sign presented in gastroscopy; (3) Received splenectomy and devascularization.

Exclusion criteria

Exclusion criteria: (1) Patinets with systemic hemorrhagic disease; (2) Abdominal bleeding after surgery.

Design outcomes

Primary

MeasureTime frame
incidence of portal thrombus and safety;—

Countries

China

Contacts

Public ContactYan Yiqun
ehbhyyq@163.com+86 021 81875501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026